Ozden Rabia Gurses 4
4 · Adverum Biotechnologies, Inc. · Filed Aug 6, 2024
Insider Transaction Report
Form 4
Ozden Rabia Gurses
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-02+44,010→ 44,010 totalExercise: $7.15Exp: 2034-08-01→ Common Stock (44,010 underlying)
Footnotes (1)
- [F1]1/3 of the total number of shares subject to the Option shall vest and become exercisable on the first anniversary of August 2, 2024 (the "Vesting Commencement Date"), and 1/36 of the total number of shares subject to the Option shall vest and become exercisable each month thereafter, such that all of the shares shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.